Superluminal Medicines Inc.
                                                                                                                                    
                                                                                                United States
                                                 -                                                 Boston, MA
                                                                                            
                                                                                    - 04/09/2023
 - Seed
 - $33,000,000
 
Superluminal Medicines is a Boston-based generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created.
Our platform creates candidate-ready compounds with unprecedented speed using a comprehensive combination of deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure. 
The predict-design-test architecture accurately models protein shapes and designs highly selective compounds to target the precise structural change for therapeutic effect. Our discovery engine is powered by an industry-leading, pharmacokinetic and toxicology in silico prediction capability. 
With a lead program candidate expected in the near term, our proprietary pipeline validates our platform with initial programs focused on high-value GPCR targets. We’re pleased to be backed by a strong network of investors including RA Capital Management, Insight Partners, NVIDIA and Gaingels.
- Industry Biotechnology Research
 - Website https://superluminalrx.com/
 - LinkedIn https://www.linkedin.com/company/superluminalrx/about/
 
Related People
Ajay YekkiralaCo Founder
                                                    
                                                                                                                United States -
                                                         Suffolk County, Massachusetts
                                                    
                                                - Dynamic thought leader and serial inventor with over 17 years of industry and academic experience in life science drug discovery and development. 
- Biotech entrepreneur with successful track record in raising capital and capacity to disrupt the CNS disease space.
- Solid team leadership and collaboration skills to build BD and scientific strategy by bringing together network of KOLs, SMEs and investors. 
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                Zeeg |  $1,265,935  | (Nov 4, 2025)
                            
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                            
                                                
                                                    
                                                
                                                    
                                                
                                                
                                                
                                                    
                                                
                                                    
                                                
                                                
                                                
                                                    
                                                
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)
                                                                        
                                octonomy |  $20,000,000  | (Nov 4, 2025)
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                Indomo |  $25,000,000  | (Nov 4, 2025)
                                                                        
                                AUI™ (Augmented Intelligence) |  $20,000,000  | (Nov 4, 2025)
                                                                        
                                Popai Health |  $11,000,000  | (Nov 4, 2025)
                                                                        
                                Mem0 |  $24,000,000  | (Oct 30, 2025)
                                                                        
                                FrontlineIQ |  $3,300,000  | (Oct 30, 2025)